Jinho Heo

Principal Scientist - Enzyme Development at Bonumose Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Charlottesville, Virginia, United States, US
Languages
  • English Full professional proficiency
  • Korean Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Principal Scientist - Enzyme Development
      • May 2021 - Present
    • United States
    • Higher Education
    • 700 & Above Employee
    • Research Scientist
      • Aug 2019 - May 2021

      • Researches for the molecular mechanisms for alloimmunization of Red blood cell (RBC) transfusion• Design, generate DNA constructs, and purify recombinant proteins for the analysis of RBC alloimmunization in mouse

    • Research Scientist
      • May 2016 - Aug 2019

      • Developed and optimized High-Throughput Screening assay to discover the inhibitors of deubiquitinase DUB3 (Collaborative Research Agreement with National Center for Advancing Translational Sciences (NCATS-NIH)• Investigated the mechanism of action for novel pharmaceutical inhibitor of protein phosphatase 2A (PP2A) (Collaborative Research Agreement with Dual Therapeutics, LLC and Bristol-Myers Squibb)• Demonstrated that the phosphorylation of SAPS3 subunit by casein kinase-2 increases PP6 phosphatase activity for Aurora A kinase. (Biochem J. 2020;477(2):431)• Showed the selective toxicity of Caffeic acid in hepatocellular carcinoma cells (Biochem Biophys Res Commun. 2918;505(2):612)• Completed Mass-Spec Proteomics of LIM Domain 7 (LMO7, a.k.a. FBXO20) interactome (Nat. Commun. 2019;10(1):1117)• Studied phosphatases, PP2A and PP6, for protein interactions, drug sensitivity and resistance • Trained and supervised graduate students and research technicians Show less

    • Research Associate
      • Jan 2014 - Apr 2016

      • Elucidated the role of Ubiquitin-Proteasome System in tumorigenesis (Semin Cancer Biol. 2016;36:33)• Demonstrated that previously known Cyclin D1 targeting ubiquitin ligase FBXO31 is irrelevant with Cyclin D1 level (In preparation)Trained and supervised graduate students and research technicians

    • United States
    • Higher Education
    • 1 - 100 Employee
    • Postdoctoral Research Associate
      • Sep 2010 - Dec 2013

      • Found Tyrosyl-DNA phosphodiesterase (TDP1) promotes assembly of Non-Homologous End Joining (NHEJ) protein complexes on DNA ends (DNA Repair. 2015;30:28) • Showed the short open reading frame (sORF)-encoded polypeptide MRI-2 physically interacts with the Ku heterodimer to stimulate DNA double strand break repair (J Biol Chem. 2014;289(16):10950) Trained and supervised graduate students and research technicians • Found Tyrosyl-DNA phosphodiesterase (TDP1) promotes assembly of Non-Homologous End Joining (NHEJ) protein complexes on DNA ends (DNA Repair. 2015;30:28) • Showed the short open reading frame (sORF)-encoded polypeptide MRI-2 physically interacts with the Ku heterodimer to stimulate DNA double strand break repair (J Biol Chem. 2014;289(16):10950) Trained and supervised graduate students and research technicians

    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant
      • Sep 2005 - Aug 2010

      • Performed the extensive functional analysis of human cytomegalovirus viral chemokines, vCXCL-1s, on human neutrophils and found that vCXCL-1s possess different levels of activity on human neutrophils (J Immunol. 2015;195(1):227) • Found there are 14 genetic groups of vCXCL-1 and they are not correlated with clinical outcomes (Virology. 2008;378(1):86) • Performed the extensive functional analysis of human cytomegalovirus viral chemokines, vCXCL-1s, on human neutrophils and found that vCXCL-1s possess different levels of activity on human neutrophils (J Immunol. 2015;195(1):227) • Found there are 14 genetic groups of vCXCL-1 and they are not correlated with clinical outcomes (Virology. 2008;378(1):86)

    • Research assistant
      • Sep 2004 - Jul 2005

      • Performed a research on CO and Methanol oxidation of mycobacterium by gene manipulation and proteomics (J Bacteriol. 2003;185(1):142) • Performed a protein profiling of mycobacterium by 2-DE and MALDI mass spectrometry Found a new potential carbon assimilation pathway in mycobacterium by identification of HPS and MNO expressions in the methanol-utilizing mycobacterium • Performed a research on CO and Methanol oxidation of mycobacterium by gene manipulation and proteomics (J Bacteriol. 2003;185(1):142) • Performed a protein profiling of mycobacterium by 2-DE and MALDI mass spectrometry Found a new potential carbon assimilation pathway in mycobacterium by identification of HPS and MNO expressions in the methanol-utilizing mycobacterium

Education

  • University of Tennessee-Knoxville
    Doctor of Philosophy (Ph.D.), Microbiology
    2005 - 2010
  • Yonsei University
    Master of Science (M.S.), Biology
    2001 - 2003
  • Gyeongsang National University
    Bachelor of Science (B.S.), Agricultural Biology
    1993 - 2010

Community

You need to have a working account to view this content. Click here to join now